v3 Template
E

Excalipoint Therapeutics

Biotechnology
Founded
--
Employees
--
Total Funding
$68.7M
Funding Rounds
1
Last Funding
2026-03-18

About Excalipoint Therapeutics

Aike Lian Biotechnology is focused on unlocking the unlimited potential of T-cell immunotherapy through innovative platforms and solutions.

Products & Services

TOPAbody Trispecific Antibody Platform:A platform for developing trispecific antibodies to enhance immunotherapy.
T Cell Engager Prodrug Platform:A platform focused on T-cell engager prodrugs for targeted immune response.
T Cell Immune Shield Platform:A platform designed to provide immune protection through T-cell mechanisms.

Specialties

T-cell Immunotherapy Trispecific Antibodies Prodrug Development Immune Protection Technologies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed 		A: 68700000
MR: -
FA: $68.7 million
FAN: 68700000 		D: 2026-03-18
FD: 2026-03-18 		11 investors
Seed Latest
2026-03-18
$68.7M
11 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Excalipoint Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro